Omega Healthcare Investors (NYSE:OHI) Reaches New 12-Month High – Time to Buy?

Omega Healthcare Investors, Inc. (NYSE:OHI)’s stock price hit a new 52-week high during trading on Thursday . The stock traded as high as $49.41 and last traded at $49.38, with a volume of 1625555 shares traded. The stock had previously closed at $48.17.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on OHI. UBS Group set a $47.00 price objective on Omega Healthcare Investors in a research note on Thursday, June 18th. Bank of America reissued an “underperform” rating and set a $46.00 target price (down from $52.00) on shares of Omega Healthcare Investors in a research report on Tuesday, April 14th. Weiss Ratings upgraded shares of Omega Healthcare Investors from a “buy (b)” rating to a “buy (b+)” rating in a report on Tuesday. BMO Capital Markets reaffirmed a “market perform” rating and set a $52.00 price target on shares of Omega Healthcare Investors in a research report on Monday, May 4th. Finally, Scotiabank decreased their price objective on shares of Omega Healthcare Investors from $50.00 to $47.00 and set a “sector perform” rating for the company in a research note on Thursday, June 18th. Five equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Omega Healthcare Investors has an average rating of “Hold” and an average target price of $48.31.

Omega Healthcare Investors Stock Down 0.0%

The firm has a 50-day simple moving average of $46.70 and a 200 day simple moving average of $45.88. The company has a debt-to-equity ratio of 0.81, a current ratio of 5.32 and a quick ratio of 5.32. The company has a market capitalization of $14.71 billion, a PE ratio of 23.86, a price-to-earnings-growth ratio of 2.10 and a beta of 0.58.

Omega Healthcare Investors (NYSE:OHI) last issued its earnings results on Tuesday, April 28th. The real estate investment trust reported $0.47 earnings per share for the quarter, missing the consensus estimate of $0.49 by ($0.02). Omega Healthcare Investors had a return on equity of 11.86% and a net margin of 51.14%.The company had revenue of $322.95 million during the quarter, compared to analysts’ expectations of $264.07 million. During the same period in the previous year, the company earned $0.75 EPS. Omega Healthcare Investors’s quarterly revenue was up 16.7% on a year-over-year basis. Omega Healthcare Investors has set its FY 2026 guidance at 3.190-3.250 EPS. On average, research analysts predict that Omega Healthcare Investors, Inc. will post 3.1 EPS for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Monday, May 4th were issued a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a yield of 5.4%. The ex-dividend date was Monday, May 4th. Omega Healthcare Investors’s dividend payout ratio is currently 129.47%.

Institutional Trading of Omega Healthcare Investors

A number of hedge funds have recently made changes to their positions in OHI. State Street Corp boosted its stake in shares of Omega Healthcare Investors by 4.8% in the second quarter. State Street Corp now owns 14,591,873 shares of the real estate investment trust’s stock valued at $534,792,000 after purchasing an additional 671,473 shares during the period. Geode Capital Management LLC increased its stake in Omega Healthcare Investors by 9.4% during the 4th quarter. Geode Capital Management LLC now owns 8,515,924 shares of the real estate investment trust’s stock worth $377,648,000 after buying an additional 734,774 shares during the period. Invesco Ltd. lifted its holdings in Omega Healthcare Investors by 8.6% in the 4th quarter. Invesco Ltd. now owns 5,368,945 shares of the real estate investment trust’s stock worth $238,059,000 after buying an additional 424,024 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in Omega Healthcare Investors by 4.1% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,463,838 shares of the real estate investment trust’s stock worth $197,927,000 after buying an additional 174,062 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its holdings in Omega Healthcare Investors by 18.5% in the 4th quarter. Bank of New York Mellon Corp now owns 4,457,975 shares of the real estate investment trust’s stock worth $197,667,000 after buying an additional 696,759 shares in the last quarter. Hedge funds and other institutional investors own 65.25% of the company’s stock.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.